/
, , , , [1].
, . (), , , , - , , [2].
, . [3], [4].
, . , . [5], [6].
:
1. BOUAZIZ J.-D. , AMY DE LA BRETEQUE M. , BAGOT M. & RYBOJAD M. Un manuel de reference en dermatologie Thérapeutique Dermatologique novembre 2012,
2. PETERSON LS, NELSON AM, SU WP. Classification of morphea (localized scleroderma). Mayo Clinic Proc, 1995, 70:1068-1076.
3. FETT N, WERTH VP. Update on morphea : part I. Epidemiology, clinical presentation and pathogenesis. J Am Acad Dermatol, 2011, 64 : 217229 ; quiz 229230.
4. FETT N, WERTH VP. Update on morphea : part II. Outcome measures and treatment. J Am Acad Dermatol, 2011, 64 : 231242 ; quiz 243244.
5. KREUTER A, HYUN J, STÜCKER M et al. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol, 2006, 54 : 440447.
6. ZULIAN F, MARTINI G, VALLONGO C et al. Methotrexate treatment in juvenile localized scleroderma : a randomized, double-blind, placebo-controlled trial. Arthritis Rheum, 2011, 63 : 1998-2006.